글로벌 플라스마 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 플라스마 치료 시장

플라스마 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 13.66%의 시장 성장을 목격할 것으로 예상됩니다. 플라스마 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 스포츠 부상 발생률의 증가는 플라스마 치료 시장의 성장을 가속화하고 있습니다.

혈액은 백혈구(WBC), 적혈구(RBC), 혈장 및 혈소판으로 구성되어 있는 것으로 알려져 있습니다. 혈장 요법에서 건강한 회복자의 면역은 혈장의 도움으로 환자에게 전달될 수 있습니다. 혈장에는 항체가 고농도로 포함되어 있기 때문입니다. 혈장 요법은 오랫동안 주로 치과, 피부과 및 정형외과에서 활용되어 왔습니다. 혈장 치료는 일반적으로 상처 치유, 안드로겐성 탈모 및 얼굴 회복에 사용됩니다.

예측 기간 동안 플라스마 치료 시장 성장을 촉진할 것으로 예상되는 주요 요인은 전 세계적으로 안드로겐성 탈모증 환자 수의 증가입니다. 또한, 여러 치료 분야에서 혈소판이 풍부한 혈장의 활용이 증가함에 따라 플라스마 치료 시장 성장이 더욱 촉진될 것으로 예상됩니다. 또한, 관절염 발병률의 증가는 플라스마 치료 시장 성장을 더욱 완화할 것으로 추산됩니다. 반면, 보상 정책의 부족과 플라스마 치료의 다양한 비용은 타임라인 기간 동안 플라스마 치료 시장 성장을 더욱 방해할 것으로 예상됩니다.

또한 정형외과적 장애와 안드로겐성 탈모증으로 고통받는 환자 수의 증가는 향후 몇 년 동안 플라스마 치료 시장 성장에 잠재적 기회를 제공할 것입니다. 그러나 당뇨병과 신장 질환을 앓고 있는 환자의 PRP 활용이 제한적이므로 가까운 미래에 플라스마 치료 시장 성장에 더욱 어려움을 겪을 수 있습니다.

This plasma therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on plasma therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Plasma Therapy Market Scope and Market Size

The plasma therapy market is segmented on the basis of type, source, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, pure platelet-rich fibrin, leukocyte-rich fibrin.
• On the basis of source, the plasma therapy market is segmented into autologous, allogenic.
• On the basis of application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, others. Orthopedics is further sub segmented into arthritis, chronic tendinitis and bone repair and regeneration. Dermatology is further sub segmented into androgenic alopecia and plastic surgery.
• On the basis of end user, the plasma therapy market is segmented into hospitals and clinics, research institutions.

Plasma Therapy Market Country Level Analysis

The plasma therapy market is analysed and market size insights and trends are provided by country, type, source, application and end user as referenced above.      

The countries covered in the plasma therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the plasma therapy market due to the rise in the number of hospitals and clinics. Furthermore, the increase in the alertness levels amongst the blood donors and the existence of the advanced protein fractioning processes will further boost the growth of the plasma therapy market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the plasma therapy market due to the rise in the medical tourism and technological developments.

The country section of the plasma therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The plasma therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for plasma therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the plasma therapy market. The data is available for historic period 2010-2019.

Competitive Landscape and Plasma Therapy Market Share Analysis

The plasma therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to plasma therapy market.

플라스마 치료 시장 보고서에서 다루는 주요 기업으로는 Arthrex, Inc., Bio Products Laboratory Ltd., Takeda Pharmaceutical Company Limited., Biotest AG., Cambryn Biologics, China Biologic Products Holdings, Inc., CSL Limited, DePuy Synthes, Grifols, SA, Kedrion SpA, Octapharma, Regen Lab SA, Stryker Corporation, Telecris Indústria e Comércio Ltda., Baxter, Japanese Red Cross Society, Sanquin Oy, LFB SA, TERUMO BCT, INC., Chengdu Institute of Biology(CIB) 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-14345